Correlation Between Ardelyx and Allovir

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Ardelyx and Allovir at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ardelyx and Allovir into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Ardelyx and Allovir, you can compare the effects of market volatilities on Ardelyx and Allovir and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ardelyx with a short position of Allovir. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ardelyx and Allovir.

Diversification Opportunities for Ardelyx and Allovir

0.69
  Correlation Coefficient

Poor diversification

The 3 months correlation between Ardelyx and Allovir is 0.69. Overlapping area represents the amount of risk that can be diversified away by holding Ardelyx and Allovir in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Allovir and Ardelyx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ardelyx are associated (or correlated) with Allovir. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Allovir has no effect on the direction of Ardelyx i.e., Ardelyx and Allovir go up and down completely randomly.

Pair Corralation between Ardelyx and Allovir

Given the investment horizon of 90 days Ardelyx is expected to generate 0.61 times more return on investment than Allovir. However, Ardelyx is 1.63 times less risky than Allovir. It trades about -0.04 of its potential returns per unit of risk. Allovir is currently generating about -0.07 per unit of risk. If you would invest  615.00  in Ardelyx on September 17, 2024 and sell it today you would lose (93.00) from holding Ardelyx or give up 15.12% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Ardelyx  vs.  Allovir

 Performance 
       Timeline  
Ardelyx 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Ardelyx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's fundamental indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.
Allovir 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Allovir has generated negative risk-adjusted returns adding no value to investors with long positions. Even with weak performance in the last few months, the Stock's basic indicators remain relatively invariable which may send shares a bit higher in January 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Ardelyx and Allovir Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Ardelyx and Allovir

The main advantage of trading using opposite Ardelyx and Allovir positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ardelyx position performs unexpectedly, Allovir can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Allovir will offset losses from the drop in Allovir's long position.
The idea behind Ardelyx and Allovir pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Other Complementary Tools

Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities